{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:41:30Z","timestamp":1792644090342,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG 2020 ID 24448"],"award-info":[{"award-number":["IG 2020 ID 24448"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012190","name":"Ministry of Science and Higher Education of the Russian Federation","doi-asserted-by":"publisher","award":["075-10-2025-017"],"award-info":[{"award-number":["075-10-2025-017"]}],"id":[{"id":"10.13039\/501100012190","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejmech.2026.119304","type":"journal-article","created":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T14:49:15Z","timestamp":1788619755000},"page":"119304","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Exploring the role of conformational restriction in 5-alkyl-6-benzyl-2-{[(methylthio)methyl]thio}pyrimidin-4(3H)-ones: Effects in HIV-1 infected cells and reverse transcriptase enzymes"],"prefix":"10.1016","volume":"320","author":[{"given":"Egor","family":"Degtyarenko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gebremedhin Solomon","family":"Hailu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Fabbrizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4991-0377","authenticated-orcid":false,"given":"Anastasia","family":"Golovina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey","family":"Voronkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0199-7730","authenticated-orcid":false,"given":"Roberta","family":"Astolfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2056-9247","authenticated-orcid":false,"given":"Lidia","family":"Giuliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5798-1698","authenticated-orcid":false,"given":"Andrea","family":"Mancini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxim B.","family":"Nawrozkij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1347-4398","authenticated-orcid":false,"given":"Vladimir","family":"Chernyshov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarissa","family":"Pupillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Cirilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7477-6314","authenticated-orcid":false,"given":"Laura","family":"Bavagnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rino","family":"Ragno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1436-5823","authenticated-orcid":false,"given":"Jos\u00e9 A.","family":"Est\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuele","family":"Crespan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3550-1860","authenticated-orcid":false,"given":"Francesco","family":"Fiorentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9573-4183","authenticated-orcid":false,"given":"Roman","family":"Ivanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9176-2382","authenticated-orcid":false,"given":"Antonello","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dante","family":"Rotili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119304_bib1","doi-asserted-by":"crossref","first-page":"5993","DOI":"10.1021\/acs.jmedchem.4c02848","article-title":"An amazing 30-Year journey around the DABO family: a medicinal chemistry lesson on a versatile class of non-nucleoside HIV-1 reverse transcriptase inhibitors","volume":"68","author":"Fabbrizi","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119304_bib2","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/med.22080","article-title":"Deciphering the enigmas of non-nucleoside reverse transcriptase inhibitors (NNRTIs): a medicinal chemistry expedition towards combating HIV drug resistance","volume":"45","author":"Zhang","year":"2025","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2026.119304_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2026.118797","article-title":"Uracil derivatives as non-nucleoside inhibitors targeting HIV-1 reverse transcriptase","volume":"310","author":"Chen","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119304_bib4","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0223-5234(92)90009-P","article-title":"Synthesis, antimicrobial and antiviral activities of isotrimethoprim and some related derivatives","volume":"27","author":"Botta","year":"1992","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119304_bib5","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1177\/095632029300400608","article-title":"3,4-Dihydro-2-alkoxy-6-benzyl-4-oxopyrimidines (DABOs): a new class of specific inhibitors of human immunodeficiency virus type 1","volume":"4","author":"Artico","year":"1993","journal-title":"Antiviral Chem. Chemother."},{"key":"10.1016\/j.ejmech.2026.119304_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/095632029500600101","article-title":"Synthesis and antiviral activity of new 3,4-dihydro-2-alkoxy-6-benzyl-4-oxopyrimidines (DABOs), specific inhibitors of human immunodeficiency virus type-1","volume":"6","author":"Massa","year":"1995","journal-title":"Antiviral Chem. Chemother."},{"key":"10.1016\/j.ejmech.2026.119304_bib7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1358\/dof.2002.027.02.653978","article-title":"Selected non-nucleoside reverse transcriptase inhibitors (NNRTIs): the DABOs family","volume":"27","author":"Artico","year":"2002","journal-title":"Drugs Future"},{"key":"10.1016\/j.ejmech.2026.119304_bib8","doi-asserted-by":"crossref","first-page":"152","DOI":"10.2174\/092986712803414169","article-title":"Dihydro-alkoxy-benzyloxopyrimidine derivatives (DABOs) as non-nucleoside reverse transcriptase inhibitors: an update review (2001-2011)","volume":"19","author":"Yang","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119304_bib9","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s11172-012-0182-7","article-title":"6-(Arylmethyl)pyrimidin-4-(3H)-ones: anthology and prospects of highly efficient anti-HIV agents","volume":"61","author":"Novakov","year":"2012","journal-title":"Russ. Chem. Bull."},{"key":"10.1016\/j.ejmech.2026.119304_bib10","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1021\/jm00017a010","article-title":"Synthesis and anti-HIV-1 activity of thio analogues of dihydroalkoxybenzyloxopyrimidines","volume":"38","author":"Mai","year":"1995","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119304_bib11","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1021\/jm960802y","article-title":"Dihydro-(alkylthio)(naphthylmethyl)oxopyrimidines: novel non-nucleoside reverse trasncriptase inhibitors of the S-DABO series","volume":"40","author":"Mai","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119304_bib12","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/S0960-894X(98)00250-9","article-title":"5-Alkyl-2-[(methylthiomethyl)thio]-6-(benzyl)-pyrimidin-4-(1H)-ones as potent non-nucleoside reverse transcriptase inhibitors of S-DABO series","volume":"8","author":"Vig","year":"1998","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.119304_bib13","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1128\/AAC.42.12.3225","article-title":"Structural-based design of dihydroalkoxybenzyloxpyrimidine derivatives as potent non-nucleoside inhibitors of the human immunodeficiency virus reverse transcriptase","volume":"42","author":"Sudbeck","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119304_bib14","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1021\/jm980260f","article-title":"5-Alkyl-2-(alkylthio)-6-(2,6-dihalophenylmethyl)-3,4-dihydropyrimidin-4(3H)-ones: novel potent and selective dihydro-alkoxy-benzyloxopyrimidine derivatives","volume":"42","author":"Mai","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119304_bib15","first-page":"30","article-title":"Does the 2-methylthiomethyl substituent really confer high anti-HIV-1 activity to S-DABOs?","volume":"10","author":"Sbardella","year":"2000","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2026.119304_bib16","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1021\/jm010853h","article-title":"Structure-based design, synthesis, and biological evaluation of conformationally restricted novel 2-alkylthio-6-[1-(2,6-difluorophenyl)alkyl]-3,4-dihydro-5-alkylpyrimidin-4(3H)-ones as non-nucleoside inhibitors of HIV-1 reverse transcriptase","volume":"44","author":"Mai","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119304_bib17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/095632020101200102","article-title":"Structure-activity relationship studies on new DABOs: effect of substitutions at pyrimidine C-5 and C-6 positions on anti-HIV-1 activity","volume":"12","author":"Sbardella","year":"2001","journal-title":"Antiviral Chem. Chemother."},{"key":"10.1016\/j.ejmech.2026.119304_bib18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/1520-636X(2001)13:2<75::AID-CHIR1001>3.0.CO;2-W","article-title":"Chiral resolution and molecular modeling investigation of rac-2-cyclopentylthio-6-[1-(2,6-difluorophenyl)ethyl]-3,4-dihydro-5-methylpyrimidin-4(3H)-one (MC1047), a potent anti-HIV-1 reverse transcriptase agent of the DABO class","volume":"13","author":"Quaglia","year":"2001","journal-title":"Chirality"},{"key":"10.1016\/j.ejmech.2026.119304_bib19","doi-asserted-by":"crossref","first-page":"8000","DOI":"10.1021\/jm050744t","article-title":"Parallel solution-phase and microwave-assisted synthesis of new S-DABO derivatives endowed with subnanomolar anti-HIV-1 activity","volume":"48","author":"Manetti","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119304_bib20","doi-asserted-by":"crossref","first-page":"6580","DOI":"10.1021\/jm0708230","article-title":"Dihydro-alkylthio-benzyl-oxopyrimidines as inhibitors of reverse transcriptase: synthesis and rationalization of the biological data on both wild type enzyme and relevant clinical mutants","volume":"50","author":"Mugnaini","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119304_bib21","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1021\/jm800340w","article-title":"5-Alkyl-6-benzyl-2-(2-oxo-2-phenylethylsulfanyl)pyrimidin-4(3H)-ones, a series of anti-HIV-1 agents of the dihydro-alkoxy-benzyl-oxopyrimidine family with peculiar structure\u2212activity relationship profile","volume":"51","author":"Nawrozkij","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119304_bib22","doi-asserted-by":"crossref","first-page":"5927","DOI":"10.1021\/jm200734j","article-title":"Modulation of cell differentiation, proliferation, and tumor growth by dihydrobenzyloxopyrimidine non-nucleoside reverse transcriptase inhibitors","volume":"54","author":"Sbardella","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119304_bib23","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1021\/jm0309856","volume":"47","author":"Ragno","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119304_bib24","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/j.bmc.2005.01.005","article-title":"5-Alkyl-2-alkylamino-6-(2,6-difluorophenylalkyl)-3,4-dihydropyrimidin-4(3H)-ones, a new series of potent, broad-spectrum non-nucleoside reverse transcriptase inhibitors belonging to the DABO family","volume":"13","author":"Mai","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119304_bib25","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.1021\/jm070811e","article-title":"Synthesis and biological properties of novel 2-aminopyrimidin-4(3H)-ones highly potent against HIV-1 mutant strains","volume":"50","author":"Mai","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119304_bib26","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/cmdc.200600310","article-title":"Slow-, tight-binding HIV-1 reverse transcriptase nonnucleoside inhibitors highly active against drug-resistant mutants","volume":"2","author":"Cancio","year":"2007","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2026.119304_bib27","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/cmdc.200800051","article-title":"Substrate-induced stable enzyme-inhibitor complex formation allows tight binding of novel 2-aminopyrimidin-4(3H)-ones to drug resistant HIV-1 reverse transcriptase mutants","volume":"3","author":"Samuele","year":"2008","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2026.119304_bib28","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1021\/jm201308v","article-title":"2-(Alkyl\/aryl)amino-6-benzylpyrimidin-4(3H)-ones as inhibitors of wild-type and mutant HIV-1: enantioselectivity studies","volume":"55","author":"Rotili","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119304_bib29","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1021\/jm101626c","article-title":"Diarylpyrimidine-dihydrobenzyloxopyrimidine hybrids: new, wide spectrum anti-HIV-1 agents active at (sub)-nanomolar level","volume":"54","author":"Rotili","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119304_bib30","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1095\/biolreprod60.6.1419","article-title":"Novel derivatives of Phenethyl-5-Bromopyridylthiourea and dihydroalkoxybenzyloxopyrimidine are dual-function spermicides with potent anti-human immunodeficiency virus activity","volume":"60","author":"D'Cruz","year":"1999","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.ejmech.2026.119304_bib31","doi-asserted-by":"crossref","first-page":"20723","DOI":"10.3390\/ijms151120723","article-title":"Synthesis and biological evaluation of 2-Thioxopyrimidin-4(1H)-one derivatives as potential non-nucleoside HIV-1 reverse transcriptase inhibitors","volume":"15","author":"Khalifa","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.119304_bib32","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/jhet.5570380323","article-title":"Synthesis and Anti-HIV activity of HEPT and S-DABO-analogues with 5-Benzyl and 5-Phenyl substituents","volume":"38","author":"Larsen","year":"2001","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2026.119304_bib33","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1023\/B:PHAC.0000008247.45050.60","article-title":"Synthesis and study of the antiviral and cytotoxic activity of 2-(alkylthio)-6- benzhydryl-4(3H)-pyrimidinones","volume":"37","author":"Navrotskii","year":"2003","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.ejmech.2026.119304_bib34","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s007060200044","article-title":"Anti-HIV active naphthyl analogues of HEPT and DABO","volume":"133","author":"Imam","year":"2002","journal-title":"Monatsch. Chem."},{"key":"10.1016\/j.ejmech.2026.119304_bib35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11094-005-0019-x","article-title":"Synthesis and anti-HIV activity of new derivatives of 6-(arylmethyl)- 2-[(cyclohexylmethyl)-thio]-4(3H)-pyrimidinone and 6-(arylmethyl)-2- {[(methylthio)methyl]thio}-4(3H)-pyrimidinone","volume":"38","author":"Navrotskii","year":"2004","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.ejmech.2026.119304_bib36","first-page":"1365","article-title":"Synthesis of some new S-DABO and HEPT analogues with expected biological activity against HBV","volume":"32","author":"Abdel Aal","year":"2006","journal-title":"Synth. Commun."},{"key":"10.1016\/j.ejmech.2026.119304_bib37","doi-asserted-by":"crossref","first-page":"5212","DOI":"10.1021\/jm500284x","article-title":"Exploring the role of 2-chloro-6-fluoro substitution in 2-alkylthio-6-benzyl-5-alkylpyrimidin-4(3H)-ones: effects in HIV-1-infected cells and in HIV-1 reverse transcriptase enzymes","volume":"57","author":"Rotili","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119304_bib38","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/cmdc.201000555","article-title":"Synthesis and biological evaluation of 6-substituted 5-alkyl-2-(phenylaminocarbonylmethylthio)pyrimidin-4(3H)-ones as potent HIV-1 NNRTIs","volume":"6","author":"Yu","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2026.119304_bib44","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1134\/S1070428010110151","article-title":"Synthesis of new derivatives of 5-Alkyl-6-(2,6-dihalobenzyl)-2-(methylsulfanyl)pyrimidin4(3H)-one and the features of their oxidation","volume":"46","author":"Novakov","year":"2010","journal-title":"Russ. J. Org. Chem."},{"key":"10.1016\/j.ejmech.2026.119304_bib45","series-title":"Method for Synthesis of Ethyl Ethers of 2-Alkyl-4-aryl-3-oxobutanoic Acids","author":"Novakov","year":"2011"},{"key":"10.1016\/j.ejmech.2026.119304_bib46","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/ardp.200900139","article-title":"Synthesis of novel uracil non-nucleoside derivatives as potential reverse transcriptase inhibitors of HIV-1","volume":"342","author":"El-Brollosy","year":"2009","journal-title":"Arch. Pharm. Chem. Life Sci."},{"key":"10.1016\/j.ejmech.2026.119304_bib39","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1055\/s-1993-25849","article-title":"A safe, economical method for the preparation of \u03b2-oxo esters","volume":"3","author":"Clay","year":"1993","journal-title":"Synthesis"},{"key":"10.1016\/j.ejmech.2026.119304_bib40","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1021\/jo00215a003","article-title":"Procedures for the acylation of diethyl malonate and ethyl acetoacetate with acid chlorides using tertiary amine bases and magnesium chloride","volume":"50","author":"Rathke","year":"1985","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2026.119304_bib41","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1021\/jo00169a053","article-title":"Improved procedure for the blaise reaction: a short, practical route to the key intermediates of the saxitoxin synthesis","volume":"48","author":"Hannick","year":"1983","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2026.119304_bib42","series-title":"Substituted N-Arylethyl-2-arylquinoline-4-carboxamides and Use Thereof","author":"Beck","year":"2018"},{"key":"10.1016\/j.ejmech.2026.119304_bib47","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1021\/acs.jmedchem.5b01979","article-title":"Development and in vitro evaluation of a microbicide gel formulation for a novel non-nucleoside reverse transcriptase inhibitor belonging to the N-Dihydroalkyloxybenzyloxopyrimidines (N-DABOs) family","volume":"59","author":"Tintori","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119304_bib48","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.ejmech.2008.06.028","article-title":"Synthesis and in vitro anti-HIV evaluation of a new series of 6-arylmethyl-substituted S-DABOs as potential non-nucleoside HIV-1 reverse transcriptase inhibitors","volume":"44","author":"Wang","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119304_bib49","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1021\/jm9600499","article-title":"Synthesis and potent anti-HIV-1 activity of novel 6-benzyluracil analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine","volume":"39","author":"Danel","year":"1996","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119304_bib50","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s007060050310","article-title":"Synthesis of 5-Alkyl-6-arylmethyl-2-(7-bromo-3,5-dioxaheptylthio)-pyrimidin-4(1H)-ones and 7-Oxopyrimidino-1,5,3-oxathiazepines as new S-DABO analogues with Anti-HIV activity","volume":"130","author":"Pedersen","year":"1999","journal-title":"Monatsh. Chem."},{"key":"10.1016\/j.ejmech.2026.119304_bib52","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1021\/ci980114i","article-title":"Molecular field topology analysis method in QSAR studies of organic compounds","volume":"40","author":"Palyulin","year":"2000","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"10.1016\/j.ejmech.2026.119304_bib53","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1021\/ci500588j","article-title":"DataWarrior: an open-source program for chemistry aware data visualization and analysis","volume":"55","author":"Sander","year":"2015","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2026.119304_bib54","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/chir.20654","article-title":"Chiral HPLC separation and absolute configuration of novel S-DABO derivatives","volume":"21","author":"Cirilli","year":"2009","journal-title":"Chirality"},{"key":"10.1016\/j.ejmech.2026.119304_bib55","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock vina 1.2.0: new docking methods, expanded force field, and python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2026.119304_bib56","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1021\/acs.jmedchem.8b01238","article-title":"Effect of alpha-Methoxy substitution on the Anti-HIV activity of Dihydropyrimidin-4(3H)-ones","volume":"62","author":"Nawrozkij","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119304_bib57","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s10822-012-9586-6","article-title":"Comprehensive model of wild-type and mutant HIV-1 reverse transciptases","volume":"26","author":"Ballante","year":"2012","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.ejmech.2026.119304_bib58","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1021\/jm0493921","article-title":"HIV-reverse transcriptase inhibition: inclusion of ligand-induced fit by cross-docking studies","volume":"48","author":"Ragno","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119304_bib59","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s10822-019-00231-x","article-title":"www.3d-qsar.com: a web portal that brings 3-D QSAR to all electronic devices-the Py-CoMFA web application as tool to build models from pre-aligned datasets","volume":"33","author":"Ragno","year":"2019","journal-title":"J. Comput. Aided Mol. Des."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119304_bib60","doi-asserted-by":"crossref","DOI":"10.1007\/s10822-026-00794-6","article-title":"Combined computational and classical medicinal chemistry procedure to disclose novel pyrrole-based compounds as potential antituberculosis agents","volume":"40","author":"Ragno","year":"2026","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.ejmech.2026.119304_bib61","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2026.119304_bib62","first-page":"2825","article-title":"Scikit-learn: machine learning in python","volume":"12","author":"Pedregosa","year":"2011","journal-title":"J. Mach. Learn. Res."},{"key":"10.1016\/j.ejmech.2026.119304_bib43","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1021\/ja312141b","article-title":"Catalytic asymmetric protonation of silyl ketene imines","volume":"135","author":"Guin","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.119304_bib63","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.antiviral.2017.03.019","article-title":"SAMHD1 is active in cycling cells permissive to HIV-1 infection","volume":"142","author":"Badia","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2026.119304_bib64","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1124\/mol.107.042911","article-title":"Anti-HIV activity and resistance profile of the CXCR4 antagonist POL3026","volume":"73","author":"Moncunill","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119304_bib65","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.antiviral.2015.09.004","article-title":"The thioacetate-\u03c9(\u03b3-lactam carboxamide) HDAC inhibitor ST7612AA1 as HIV-1 latency reactivation agent","volume":"123","author":"Badia","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2026.119304_bib66","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1006\/jmbi.1997.1427","article-title":"Resistance to nevirapine of HIV-1 reverse transcriptase mutants: loss of stabilizing interactions and thermodynamic or steric barriers are induced by different single amino acid substitutions","volume":"274","author":"Maga","year":"1997","journal-title":"J. Mol. Biol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342600749X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342600749X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:28:08Z","timestamp":1792643288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352342600749X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":65,"alternative-id":["S022352342600749X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119304","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the role of conformational restriction in 5-alkyl-6-benzyl-2-{[(methylthio)methyl]thio}pyrimidin-4(3H)-ones: Effects in HIV-1 infected cells and reverse transcriptase enzymes","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119304","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119304"}}